Accredited downgrade threat on hold as R&Q agrees $465m sale to Onex

down-arrow2

R&Q Insurance Holdings has entered into a conditional agreement with Canadian investment business Onex Corporation to sell 100% of the equity interest in its front business Accredited.

The deal, which first floated in September, is subject to shareholder approval, regulatory approval and customary consents from certain R&Q debt providers.

Upon completion, R&Q will refocus as a legacy insurance business in Bermuda, Europe, the US and the UK.

Related R&Q in ‘advanced’ talks for sale of Policy Expert capacity backer Accredited

R&Q is in discussions with Canadian investment business Onex for the sale of its fronting business Accredited.

R&Q said the proposed

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

Broking Success: Fiercely independent

Paul Wadsworth, managing director of FR Ball, is looking to grow the business to £24m gross written premiums as it aims to offer soft landings for acquisitions.

Government starts discount rate review

The Ministry of Justice has confirmed the start of the 2024 review of the personal injury discount rate in England and Wales with a decision due no later than 11 January 2025.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: